's esophagus is characterized by a distinct Th2-predominant cytokine profile (IL-4) from in vivo or ex vivo evidence. The detailed role of cytokines in Barrett's esophagus, particularly whether Th2 cytokines are causative factors driving metaplastic processes, remains unknown. In this study, airliquid interface-cultured human esophageal epithelial cells were stimulated by a Th2 cytokine, IL-4, and Th1 cytokines, TNF-␣ and IL-1␤, continuously for 10 days. Barrier function was determined by transepithelial electrical resistance. Morphological changes were investigated by hematoxylin and eosin staining. Keratin profile (keratin 7, 8, 13, and 14) and squamous differentiation markers (involucrin) were investigated by RT-quantitative PCR, Western blotting, and immunohistochemical staining. Pharmacological inhibitors were used to identify the underlying cellular signaling. We report that IL-4, TNF-␣, and IL-1␤ decrease barrier function, but only IL-4 significantly increases cell layers and changes cell morphology. IL-4 time dependently downregulates the expression levels of the squamous cell markers involucrin and keratin 13 and upregulates the expression levels of the columnar cell markers keratin 7 and 8. Neither TNF-␣ nor IL-1␤ shows any effect on these indexes. JAK inhibitor I and PI3K inhibitors significantly block the IL-4-induced changes in the levels of keratin 8 and 13. In conclusion, IL-4 inhibits squamous differentiation program of esophageal epithelial cells and induces differentiation toward columnar cells through the JAK/PI3K pathway. Thus IL-4 may be involved in the early stages of Barrett's esophagus development.
The detailed role of cytokines in Barrett's esophagus, particularly whether Th2 cytokines are causative factors driving metaplastic processes, remains unknown. In this study, airliquid interface-cultured human esophageal epithelial cells were stimulated by a Th2 cytokine, IL-4, and Th1 cytokines, TNF-␣ and IL-1␤, continuously for 10 days. Barrier function was determined by transepithelial electrical resistance. Morphological changes were investigated by hematoxylin and eosin staining. Keratin profile (keratin 7, 8, 13, and 14) and squamous differentiation markers (involucrin) were investigated by RT-quantitative PCR, Western blotting, and immunohistochemical staining. Pharmacological inhibitors were used to identify the underlying cellular signaling. We report that IL-4, TNF-␣, and IL-1␤ decrease barrier function, but only IL-4 significantly increases cell layers and changes cell morphology. IL-4 time dependently downregulates the expression levels of the squamous cell markers involucrin and keratin 13 and upregulates the expression levels of the columnar cell markers keratin 7 and 8. Neither TNF-␣ nor IL-1␤ shows any effect on these indexes. JAK inhibitor I and PI3K inhibitors significantly block the IL-4-induced changes in the levels of keratin 8 and 13. In conclusion, IL-4 inhibits squamous differentiation program of esophageal epithelial cells and induces differentiation toward columnar cells through the JAK/PI3K pathway. Thus IL-4 may be involved in the early stages of Barrett's esophagus development.
Barrett's esophagus; IL-4; columnar-like differentiation; barrier function; cytokine BARRETT'S ESOPHAGUS (BE) is an acquired condition in which the distal esophagus in gastroesophageal reflux disease (GERD) patients is replaced with a squamous to columnarlined epithelium, often with intestinal features (33) . Around 10% of GERD patients will develop BE (29) . Despite the higher capacity of Barrett's epithelium to handle acid, BE is a premalignant lesion that can progress from metaplasia to dysplasia and to esophageal adenocarcinoma at rates reported to range from 0.12 to 0.5% per year (16) .
Substantial debate exists about the origin of cells in BE and the underlying molecular mechanisms (35) . Several theories have been proposed regarding BE cell origin: for example, impaired esophageal epithelium replaced by the migration of gastric cardia epithelium (27) or by the colonization by circulating multipotent bone marrow stem cells (36) . However, the most predominant concept is squamous stem cell reprogramming toward columnar epithelial cells with intestinal characteristics (46) . This is supported by the observation of multilayered epithelium in BE, which has histological features of both squamous and columnar epithelium and may represent a transitional stage in the genesis of Barrett's epithelium, suggesting that stratified squamous epithelium may give rise to Barrett's epithelium (6, 12, 43) .
Since acid reflux and reflux of duodenal contents are elevated in patients with BE compared with GERD patients without BE, chronic gastroesophageal reflux containing acid and bile appears to play a crucial role in the development of BE (28) . Previous studies also demonstrated the effects of acid (41) or bile acid (20, 21) on induction of caudal type homeobox 2 (CDX2) in esophageal epithelial cells. Other than direct stimulation by intraluminal reflux contents, esophageal epithelial cells are also immersed in a chronic inflammatory environment. Distinct anti-inflammatory Th2-predominant cytokine profiles have been characterized in BE, compared with the proinflammatory nature in GERD (11, 49) . Compared with patients without erosions, IL-8, IL-1␤, and IFN-␥ are upregulated in the esophageal mucosa of patients with erosive esophagitis, indicating a Th1-predominant cytokine profile. In contrast, in Barrett's epithelium none of these cytokines are modified, only IL-4 is fourfold upregulated, and, more interestingly, IL-4/T cell receptors are 200-fold upregulated (11) . In addition, the proportion of Th2 effector cells (plasma cells and mast cells) was higher in esophageal biopsy specimens obtained from BE patients than esophagitis patients (26) . A previous study demonstrated IL-4 mRNA before upregulation of CDX2 mRNA in a BE animal model (22) . These data indicate that IL-4 may play a crucial role in the development of BE in an early phase. On the other hand, IL-4 is known to induce expression of mucin (MUC) 2 and the differentiation of epithelial cells to goblet cells in a human pulmonary mucoepidermoid cell line (7) . Similar findings in mice demonstrated that IL-4-producing CD4ϩ T cells induce the differentiation of intestinal epithelia cells into goblet cells (8) , suggesting the potential function of IL-4 to differentiate epithelial cells. However, the detailed role of cytokines in the genesis of BE, particularly whether cytokines such as IL-4 can be causative factors driving metaplastic processes, remains unknown.
Despite the different Th cytokine profile involved, a common functional alteration in erosive esophagitis and BE epithelium is the presence of impaired mucosal integrity. This feature is observed in patients with BE as a result of the change to columnar epithelium and in eroded areas in patients with erosions. Nevertheless, mucosal integrity is also impaired in grossly normal-appearing mucosa (18) and, more interestingly, in restored stratified neosquamous epithelium (14, 19) of BE patients after endoscopic ablation by radiofrequency. These observations indicate that cytokines still present in the epithelium can have a role in impaired mucosal integrity present in erosive esophagitis and BE.
The role of Th1 and Th2 cytokines in differentiation and esophageal mucosa integrity has been never assessed. One critical limitation to explore the involvement of cytokines in the pathogenesis of BE and erosive esophagitis has been the lack of research models. Previous in vitro studies have mainly been based on monolayers with immortalized cell lines (15) or adenocarcinoma cell lines (2) , which are far from the in vivo condition and are inappropriate for investigating the initiation of the metaplastic transformation. Therefore, in this study, we introduced a 3D primary stratified squamous epithelial model with normal human esophageal epithelial cells (HEECs) to explore the effects of chronic cytokines stimulation on the differentiation and barrier function of squamous epithelial cells (4) . Morphological changes, keratin, and squamous differentiation marker profiles were investigated by use of a Th2 cytokine, IL-4, and Th1 cytokines, TNF-␣ and IL-1␤. Moreover, the intracellular mechanisms involved in changes in IL-4-induced cell phenotype markers were also evaluated.
MATERIALS AND METHODS
Cell culture. HEECs were purchased from ScienCell Research Laboratories (Carlsbad, CA). Cells were cultured in epithelial cell medium-2 (EpiCM-2; ScienCell Research Laboratories) and were subcultured in Transwell-Clear wells (Costar, Cambridge, UK) until reaching ϳ80% confluency. Then, air-liquid interface (ALI) culture, as described previously (5, 30, 31) , was performed. Stratified squamous epithelial 3D models were ready after 10 days of ALI culture.
Reagents. IL-4, TNF-␣, and IL-1␤ were purchased from R&D Systems (Minneapolis, MN). JAK inhibitor I, SB203580 (inhibitor of p38 MAPK), PD98059 (inhibitor of ERK), and JNK inhibitor II were purchased from Calbiochem (Milan, Italy). Wortmannin [irreversible inhibitor of phosphatidylinositol 3-kinase (PI3K)] and LY294002 (reversible inhibitor of PI3K) were purchased from Cayman Chemical (Ann Arbor, MI).
Construction of experimental model and various treatments. In our model, each well had an apical and basolateral compartment, representing the luminal and subepithelial sides of the esophagus, respectively. Cells were stimulated from the basolateral compartments with IL-4 (10 ng/ml), TNF-␣ (10 ng/ml), and IL-1␤ (1 ng/ml) for 10 continuous days of stimulation (from ALI culture day 1 to day 10). In some experiments, 1, 3, or 5 days of stimulation were also used for reported previously (32) . The values obtained from a blank insert were subtracted to give the net resistance, which was multiplied by the membrane area to give the resistance in area-corrected units (⍀·cm 2 ). The change in electrical resistance was represented by percentage baseline resistance, as described previously (32) . Transepithelial electrical resistance (TEER) values were recorded after 10-day stimulation.
Measurement of mRNA. Cells were collected after 10 days of stimulation, or at 1-to 5-day intervals. Total mRNA was extracted by using the RNeasy Micro Kit (Qiagen, Hilden, Germany). cDNA was synthesized by High Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster City, CA). PCR was carried out with a PCR master mix in a 7900HT Fast Real-Time PCR System (Applied Biosystems). TaqMan probes and primers for involucrin (Hs00846307_s1), keratin 13 (Hs02558881_s1), keratin 7 (Hs00559840_m1), and keratin 8 (Hs01595539_g1) were assay-on-demand gene expression products obtained from Applied Biosystems. The GAPDH gene was used as an endogenous control (Hs02758991_g1). Amplification data were analyzed with an Applied Biosystems Sequence Detection Software version 2.2 (Applied Biosystems). The ⌬⌬CT method recommended by the manufacturer was used to compare relative expression levels.
Western blotting analysis. Protein was extracted by reduced lysis buffer [60 mM Tris·HCl (pH 6.8), 10% glycerol, 1 tab protein inhibitor] for the total fraction. Protein concentrations were determined with the Bradford assay kit (Bio-Rad Laboratories, Hercules, CA).
Equal quantities of protein were separated on 10% SDS-PAGE gels, and transferred to nitrocellulose membranes (Hybond ECL; GE Healthcare UK, Buckinghamshire, UK). Membranes were incubated with mouse anti-involucrin (Abcam, Cambridge, UK) (1:1,000), mouse anti-keratin 13 antibody (Leica Microsystems, Wetzlar, Germany) (1:1,000), mouse anti-keratin 7 (Abcam) (1:500), mouse antikeratin 8 (Abcam) (1:500), or mouse anti-␤-actin (Sigma, St. Louis, MO) (1:2,000) overnight at 4°C. Then, after incubation with horseradish peroxidase-conjugated anti-mouse IgG antibody, proteins were visualized by using a Luminescent Image Analyzer (ImageQuant Imager 350 system; GE Healthcare Life Sciences, Tokyo, Japan). The Western blotting bands were analyzed by ImageJ software (Bio-Arts, Fukuoka, Japan).
Hematoxylin and eosin staining and immunostaining. Healthy and BE subjects were recruited for the esophageal biopsies and gave written, informed consent as approved by the ethics committee. Biopsies were taken from normal squamous epithelia and from BE in the distal esophagus. The 10% formalin-fixed biopsies were routinely processed, paraffin embedded, and sections (3 m thick) were cut and prepared for immunohistochemistry. stratified epithelial layers were fixed with 2% neutral formalin solution and were embedded in paraffin. Hematoxylin and eosin staining was performed by standard procedures. For immunohistochemistry, staining was performed as described previously (37) . Antigen retrieval was performed by autoclaving for 10 min at 121°C in antigen retrieval solution (Histo VT one; Nacalai Tesque, Kyoto, Japan). For keratin 8 staining, 1 mM EDTA (pH 7.4) was used for antigen retrieval. Mouse anti-involucrin (Abcam) (1: 100), mouse anti-keratin 7 (Abcam) (1:100), mouse anti-keratin 13 (Leica Microsystems) (1:100), mouse anti-keratin 8 antibody (CAM 5.2, ready-to-use, Becton Dickson, San Jose, CA), mouse anti-keratin 14 (Leica Biosystems, Newcastle, UK) (1:40), and mouse anti-Ki67 (ready-to-use, Invitrogen, Carlsbad, CA) were used. Reaction specificity was tested by incubation with antibody diluent (Dako, Carpinteria, CA). Ki67 staining was semiquantified by calculating the average number of positive cells in five high-power fields.
Statistical analysis. All values are presented as means Ϯ SD. Data were analyzed by one-way ANOVA followed by Fisher's protected least significant difference test or Scheffé's F-test for multiple comparisons. Significance was accepted at P Ͻ 0.05.
RESULTS

IL-4 altered mucosal integrity, cell morphology, and proliferation. TEER was significantly decreased in IL-4-, TNF-
␣-, and IL-1␤-treated groups after 10 days of stimulation ( Despite the impaired integrity induced by these three cytokines, only IL-4 induced changes in epithelial morphology and cell proliferation. The epithelium was thicker (Fig. 1, C-F ) by almost twofold (Fig. 1B) , and the basal cell layer contained more cells (hyperplasia) and appeared crowded and more disorganized compared with untreated cells. Staining for Ki67-positive cells demonstrated a twofold increase in cell proliferation in 10-day IL-4 treated HEECs (Fig. 1G) , and the Ki67-positive cells were confined not only to the basal layer, but also to two or three layers beyond basal layer (Fig. 1, H-I) .
IL-4 altered squamous cell differentiation. IL-4, but not TNF-␣ or IL-1␤, treatment for 10 days on ALI-cultured HEECs downregulated mRNA levels of the squamous epithelial cell markers involucrin and keratin 13 to 0.37 Ϯ 0.02-and 0.12 Ϯ 0.03-fold, respectively (Fig. 2, A and B) , and upregulated the mRNA levels of the columnar cell markers keratin 8 and 7 to 3.85 Ϯ 1.19-and 2.44 Ϯ 0.22-fold, respectively (Fig.  2, C and D) (P Ͻ 0.05).
Similar findings were observed at the protein level, thus confirming IL-4-induced changes in cell phenotype markers (Fig. 3) . Involucrin and keratin 13 were downregulated to 52% and 48%, and keratin 8 and 7 were upregulated 2.5-and 1.2-fold, respectively (P Ͻ 0.05). Moreover, immunohistochemistry reflected the localization of these epithelial markers (Fig. 4) . Staining of involucrin was seen in all layers under control conditions, and the staining of involucrin was lower in basal and suprabasal layers under IL-4-treated conditions (Fig.  4, A and B) . Superficial staining of keratin 13 was observed under control conditions and became undetectable after IL-4 treatment (Fig. 4, E and F) . Keratin 8 staining was located in basal and suprabasal layers and increased after IL-4 treatment (Fig. 4, I and J) . Low expression of keratin 7 was observed under control conditions, but after stimulation with IL-4 increased staining for keratin 7 was observed in suprabasal layers (Fig. 4, M and N) . Keratin 14 as the immature basal squamous marker can still be detected in the basal and suprabasal layers in the IL-4-treated group (Fig. 4, Q and R) . after 1 day of stimulation with IL-4. Keratin 13 was downregulated to 0.34 Ϯ 0.02-fold and keratin 8 was upregulated 11.18 Ϯ 2.6-fold. In contrast, changes in expression of involucrin and keratin 7 were seen at later time points. After 3 days, involucrin was downregulated to 0.24 Ϯ 0.02-fold and keratin 7 was upregulated 2.86 Ϯ 0.35-fold (Fig. 5) . Similar changes in expression at the protein level were also observed, but except for keratin 13, these changes occurred later compared with mRNA expression. Keratin 13 was downregulated after 1 day of incubation with IL-4 and was more intense after 3 and 5 days (30 and 27%, respectively) compared with control conditions. Involucrin protein levels were significantly lower after 5 days (68%) of IL-4 stimulation. Keratin 8 and keratin 7 protein levels were significantly higher after 3 and 5 days of stimulation with IL-4 (to 3.1-and 1.4-fold, respectively) (Fig. 6) .
JAK/PI3K pathway was involved in the IL-4-induced changes in squamous cell differentiation program. JAK inhibitor I partially blocked the IL-4-induced decrease in keratin 13 mRNA and increase in keratin 8 mRNA. P38 MAPK, ERK, and JNK inhibitors showed no effects on the IL-4-induced changes in keratin 13 and keratin 8. Both of the two specific PI3K inhibitors (wortmannin and LY294002) totally blocked the IL-4-induced decreases in keratin 13 and increases in keratin 8 (Fig. 7) .
DISCUSSION
Here, we showed for the first time that IL-4 is able to drive columnar-like differentiation in esophageal squamous epithelium. IL-4-treated primary human esophageal epithelial cell layers in our in vitro 3D model clearly expressed the columnar cell markers keratin 7 and 8, which were also expressed in BE (3, 44) , and keratin 7 was confirmed to be an early marker of reflux-related columnar mucosa without intestinal metaplasia in the esophagus (3). Although overall epithelia retained stratified morphology after IL-4 stimulation, the squamous differentiation marker involucrin and squamous cell marker keratin 13 were significantly decreased, and the morphology of stratified layers represented more disorganized and columnar-like cells on the basal side of the layers. The basal and suprabasal layer cells expressed both the immature basal squamous marker, keratin 14, and the columnar cell marker, keratin 8, implying a retarded squamous differentiation and columnarlike directed differentiation. This mixed cell multilayer epithelium to some extent simulated the multilayered epithelium observed in BE; both had histological features of squamous and columnar epithelium (12) .
Moreover, we also showed for the first time a direct effect of Th1 and Th2 cytokines on esophageal mucosa integrity. Although this was an in vitro observation, we believe that the fact that we used a 3D model of primary human esophageal epithelium and that cytokines were applied to the basolateral side makes this observation very relevant. It is generally established that the presence of impaired mucosa integrity observed in GERD patients, erosive and nonerosive form (10) , is due to a direct effect of luminal agents as acid, bile acids, pepsin, and trypsin (9) . Nevertheless, the caustic theory about the damage of the esophageal epithelium was challenged by Souza et al. (40) , who suggested that cytokine-mediated mechanisms rather than a direct effect of gastric compounds lead to esophagitis. Although several studies have indicated that TNF-␣ (24), IL-1␤ (1), and IL-4 (25) are able to decrease the barrier function of the intestine, their roles in esophageal mucosa have not been evaluated. Our observations indicate that the cytokines present in erosive esophagitis and BE play a crucial role in impaired mucosal integrity and may explain why the grossly normal appearing epithelium of GERD or restored stratified neosquamous epithelium of BE have impaired mucosal integrity (19) . However, JAK inhibitor was unable to restore the IL-4-induced decrease in TEER (data not shown), and the potential mechanisms of cytokines-induced barrier dysfunction remain an open question. Further studies are thus necessary.
Most previous in vitro esophageal epithelial models were based on immortalized epithelial cell lines (15) or adenocarcinoma cell lines (2) , which undoubtedly possess numerous genetic and cytogenetic abnormalities compared with native tissue. We established this in vitro 3D primary human esophageal squamous epithelial cell model, which shows similarities with esophageal epithelium in vivo with respect to morphology, molecular marker expression, and barrier function (4) and has been evaluated in previous studies (4, 5, 37, 38) . On the basis of the normal esophageal epithelial cell origin, squamous stem cells on the basal side can be reprogrammed toward a simple epithelial lineage under specific conditions. In addition, this model provides a more visible change compared with monolayer cultured cells, such as the increased cell layers, basal cell morphological changes, and the localization of specific markers. Thus it appears to be a suitable epithelial model to investigate the mechanisms of the metaplastic transformation.
Mucosal inflammation is a common mechanism in the pathogenesis of epithelial metaplasia in many tissues and may induce changes in the commitment of one cell type to another (39) . Several studies have investigated inflammatory profiles in the mucosa in esophagitis and BE, and proinflammatory cytokines including IL-1␤, IL-8, and TNF-␣ were upregulated in esophagitis compared with BE (11, 42) , whereas IL-4 was only elevated in BE (11, 26, 49) . However, few studies have investigated whether these cytokines drove metaplastic transformation. A recent study showed esophageal overexpression of IL-1␤ in a transgenic mouse model gave rise to Barrett'slike metaplasia (34) . However, in our study, TNF-␣ or IL-1␤ did not induce cell phenotype markers or induce BE-specific markers such as CDX2 (data not shown). The differences may be due to limited stimulation time and pure and simple stimulation compared with the in vivo experiments. On the basis of our in vitro study, IL-4 is able to retard squamous cell differentiation program and induce columnar-like differentiation but does not induce the metaplastic transformation of BE. BErelated markers, such as CDX-2, MUC2, and MUC5AC, were not induced and not detectable in message level by IL-4 stimulation (data not shown). This may be because, other than for a chronic inflammation environment, triggers such as acid and bile acid can be cooperatively involved in metaplastic transformation (34, 41) . We speculate that more than one trigger is necessary to induce esophageal stem cells toward BE epithelial cells. Another interesting finding in this study is the pathway involved in the IL-4-induced cell phenotype markers conversion. The IL-4 signaling pathway has been extensively explored in previous studies (17) . IL-4 activates JAKs followed by the activation of signal transducer and activator of transcription-6 (STAT6), which is a transcription factor playing a predominant role in the immune system (13) . In addition to the JAK/STAT6 pathway, IL-4 also activates a variety of other signaling molecules, such as PI3K and MAPK, which are important in regulating IL-4-induced proliferation and protection from apoptosis (45, 48) . As shown here, IL-4 altered keratin 8 and 13 (columnar and squamous cell markers, respectively). Therefore, we selected these as target genes to investigate the possible signal pathways. The blocking experiment showed that JAK and PI3K, but not MAPK, were involved in the IL-4-induced cell phenotype marker conversion and that PI3K inhibitors completely blocked the effect, indicating that PI3K was the main pathway in IL-4-induced changes.
It remains unclear how cytokine profiles are Th1 predominant in GERD and Th2 predominant in BE. Global alteration of the microbiome of inflammation and intestinal metaplasia of the distal esophagus (47) may be one reason. Another study showed that the immune cell composition was similar in BE and the duodenum and argued that the homing of lymphocytes to BE tissue was mainly caused by intestinal homing signals rather than to an active inflammatory response (23) . Th2 cytokines might be the result but not the cause of BE; however, this hypothesis was not supported by animal BE experiments, which showed increased IL-4 mRNA levels before the induction of CDX2 mRNA (22) . Irrespective of whether Th2 cytokines are the initial factors or maintaining factors in BE, our study suggests a role for IL-4 in the columnar-like differentiation of esophageal squamous epithelium. Therefore, identifying the possible mechanisms involved in the transition of proinflammatory cytokines to Th2 cytokines in the formation of BE may provide new insight into the clinical management of BE patients.
There are some limitations in this study. First, all the studies were done on the stratified squamous esophageal epithelial model, which limited our means of more selective inhibition, such as siRNA, to explore the underlying mechanisms. Second, in our study we did not prove the existence of squamous stem cells. Therefore, we cannot conclude whether the columnarlike conversion is the differentiation from stem cell or transdifferentiation from squamous cells.
In conclusion, IL-4, but not TNF-␣ or IL-1␤, retarded squamous cell differentiation program and induced columnarlike differentiation. The JAK/PI3K pathway was involved in the IL-4-induced cell phenotype markers conversion. IL-4 may be involved in the development of BE at early stages. Therapeutic strategies designed to abolish the effects of IL-4 may provide a preventive strategy for BE.
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